[11C]-APP311
Cannabis Use Disorder
Yale UniversitySmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
8 Active assets in the Cannabis Use Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Clozapine Dartmouth-Hitchcock Medical Center | Phase 4 | BB |
Topamax University of Cincinnati | Phase 4 | BB |
Seroquel® University of Cincinnati | Phase 4 | BB |
Risperdal Dartmouth-Hitchcock Medical Center | Phase 4 | BB |
Metformin Nova Scotia Health Authority | Phase 4 | BB |
View all 15 →
Same molecule, other indications
[11C]-APP311 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →